Review article · 2023 · Open access

Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities

Pingping Yang, Jun Tao Ren, Lifang Yang

International Journal of Molecular Sciences, 24(6), 5205 · Published 8 March 2023 · DOI 10.3390/ijms24065205

Open PDFView at the publisherCite this paper

In brief

“Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities” is a 2023 review article by Pingping Yang and 2 co-authors, published in International Journal of Molecular Sciences. OpenAlex counts 39 citations as of 19 November 2026, which puts it in the top 7% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at International Journal of Molecular Sciences.

Citations
39
Most cited in
2025 (14)
Field-weighted impact
0.55
References
93
Authors
3

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Although a cadre of therapeutic strategies have been made available for CVDs in the clinical setting, predominantly through medication and surgery, these do not fully address the clinical needs of patients with CVD. As a new technique for CVD treatment, nanocarriers are employed to modify and package medications to ease the targeting of tissues, cells and molecules within the cardiovascular system. Nanocarriers are made of biomaterials, metals, or a combination of these materials, with sizes similar to bioactive molecules such as proteins and DNA. Cardiovascular nanomedicine (CVN) has only surfaced in recent years and is still in its infancy. Ample studies have displayed promise for the clinical utility of nanomedicine techniques, courtesy of continued perfection in nanocarrier design to optimize drug delivery and treatment outcomes. Here in this review, we will summarize the research advances in the literature on nanoparticles in the management of CVDs, including ischemic and coronary heart disease (e.g., atherosclerosis, angina pectoris and myocardial infarction), myocardial ischemia-reperfusion injury, aortic aneurysm, myocarditis, hypertension, and pulmonary artery hypertension and thrombosis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yang, P., Ren, J. T., & Yang, L. (2023). Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities. International Journal of Molecular Sciences, 24(6), 5205. https://doi.org/10.3390/ijms24065205

MLA 9

Yang, Pingping, et al. “Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities.” International Journal of Molecular Sciences, vol. 24, no. 6, 2023, p. 5205. https://doi.org/10.3390/ijms24065205.

Chicago

Yang, Pingping, Jun Tao Ren, and Lifang Yang. 2023. “Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities.” International Journal of Molecular Sciences 24 (6): 5205. https://doi.org/10.3390/ijms24065205.

Harvard

Yang, P., Ren, J. T. and Yang, L. (2023) ‘Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities’, International Journal of Molecular Sciences, 24(6), p. 5205. doi:10.3390/ijms24065205.

IEEE

P. Yang, J. T. Ren, and L. Yang, “Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities,” International Journal of Molecular Sciences, vol. 24, no. 6, p. 5205, 2023, doi: 10.3390/ijms24065205.

BibTeX

@article{yang2023nanoparticles,
  title     = {{Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities}},
  author    = {Yang, Pingping and Ren, Jun Tao and Yang, Lifang},
  journal   = {International Journal of Molecular Sciences},
  year      = {2023},
  volume    = {24},
  number    = {6},
  pages     = {5205},
  doi       = {10.3390/ijms24065205},
  url       = {https://doi.org/10.3390/ijms24065205}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202322
20241010
20251414
20261313

Its field-weighted citation impact is 0.55: it has been cited 0.55 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • nanoparticles
  • nanocarriers
  • drug delivery
  • cardiovascular disease
  • atherosclerosis
  • myocardial ischemia-reperfusion injury
  • aortic aneurysm
  • myocarditis

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Yang, P., Ren, J. T., & Yang, L. (2023). Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities. International Journal of Molecular Sciences, 24(6), 5205. https://doi.org/10.3390/ijms24065205

How many times has this paper been cited?

39 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Molecular Sciences: sign in and open the PDF from this page.

Who wrote this paper?

Pingping Yang, Jun Tao Ren, Lifang Yang.

What is the DOI of this paper?

10.3390/ijms24065205, permanently at https://doi.org/10.3390/ijms24065205. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.